Clinical Trial Update: Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas [Phase 2]

View source ↗

Summary

Phase II trial of binimetinib in children and adults with NF1-associated plexiform neurofibromas has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Binimetinib (binimetinib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Neurofibromatosis Type 1, Plexiform Neurofibroma | Phase 2 | Status: COMPLETED | Results posted: 2025-05-02